A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis Alberto Jiménez-Morales, Rafael Cáliz, Susana Aceituno, Miriam Prades, Carles Blanch

Anti-MDA5 dermatomyositis mimicking psoriatic arthritis Iván Cabezas-Rodríguez, Isla Morante-Bolado, Anahy Brandy-García, Rubén Queiro-Silva, Lourdes Mozo, Francisco Javier Ballina-García

Health-related quality of life in psoriatic arthritis patients in Spain Jordi Gratacós, Esteban Daudén, Juan Gómez-Reino, José Carlos Moreno, Miguel Ángel Casado, Vicente Rodríguez-Valverde